Page last updated: 2024-10-18

glycolic acid and Androgen-Independent Prostatic Cancer

glycolic acid has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

glycolic acid: RN given refers to parent cpd
glycolic acid : A 2-hydroxy monocarboxylic acid that is acetic acid where the methyl group has been hydroxylated.

Research Excerpts

ExcerptRelevanceReference
"Myricetin was identified as a potent α-ketoglutarate-type inhibitor that blocks the demethylation activity by KDM4s and significantly reduced the proliferation of both androgen-dependent (LNCaP) and androgen-independent CRPC (CWR22Rv1 and C4-2B)."1.72Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer. ( Chen, CM; Chen, TJ; Chen, YC; Chuu, CP; Fang, WK; Hsieh, HP; Kung, HJ; Lin, TY; Liu, JS; Liu, KL; Wang, LY; Wang, WC; Wu, CM; Wu, MC; Yang, SM, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liu, JS1
Fang, WK1
Yang, SM1
Wu, MC1
Chen, TJ1
Chen, CM1
Lin, TY1
Liu, KL1
Wu, CM1
Chen, YC1
Chuu, CP1
Wang, LY1
Hsieh, HP1
Kung, HJ1
Wang, WC1

Other Studies

1 other study available for glycolic acid and Androgen-Independent Prostatic Cancer

ArticleYear
Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer.
    Journal of biomedical science, 2022, May-09, Volume: 29, Issue:1

    Topics: Androgens; Animals; Antineoplastic Agents; Biological Products; Cell Line, Tumor; Cell Proliferation

2022